Published in CA Cancer J Clin on November 14, 2012
Robotic right colectomy: A worthwhile procedure? Results of a meta-analysis of trials comparing robotic versus laparoscopic right colectomy. J Minim Access Surg (2015) 0.93
Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study. Breast (2016) 0.87
Role of robot-assisted distal gastrectomy compared to laparoscopy-assisted distal gastrectomy in suprapancreatic nodal dissection for gastric cancer. Surg Endosc (2015) 0.85
Who should adopt robotic surgery, and when? Ann Thorac Surg (2013) 0.75
A novel approach emphasising intra-operative superficial margin enhancement of head-neck tumours with narrow-band imaging in transoral robotic surgery. Acta Otorhinolaryngol Ital (2015) 0.75
Robotics in general surgery: A systematic cost assessment. J Minim Access Surg (2016) 0.75
Musculoskeletal pain among surgeons performing minimally invasive surgery: a systematic review. Surg Endosc (2016) 0.75
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology (2012) 6.35
Marital status and survival in patients with cancer. J Clin Oncol (2013) 5.82
Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol (2011) 4.60
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology (2013) 2.99
Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J Urol (2012) 2.94
Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J Urol (2012) 2.79
Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy. J Urol (2010) 2.77
Economic costs of overactive bladder in the United States. Urology (2009) 2.68
Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39
Influence of surgeon and hospital volume on radical prostatectomy costs. J Urol (2012) 2.37
Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology (2010) 2.31
Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Urology (2011) 2.24
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol (2012) 2.22
Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int (2013) 2.12
Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Eur Urol (2011) 2.09
Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy. J Urol (2011) 2.05
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology (2013) 2.04
Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol (2012) 1.86
Utilization and expense of adjuvant cancer therapies following radical prostatectomy. Cancer (2011) 1.85
Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy. Urology (2010) 1.83
Genome size is a strong predictor of cell size and stomatal density in angiosperms. New Phytol (2008) 1.80
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. J Urol (2012) 1.78
Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Eur Urol (2011) 1.76
Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol (2014) 1.74
Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int (2013) 1.73
Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res (2010) 1.71
Structural consequences of diffuse traumatic brain injury: a large deformation tensor-based morphometry study. Neuroimage (2007) 1.63
Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Urology (2013) 1.63
Athermal division and selective suture ligation of the dorsal vein complex during robot-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2010) 1.58
Trends in the care of radical prostatectomy in the United States from 2003 to 2006. BJU Int (2010) 1.57
A systematic review of the volume-outcome relationship for radical prostatectomy. Eur Urol (2013) 1.48
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol (2003) 1.47
Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function. Eur Urol (2012) 1.45
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size. Int J Radiat Oncol Biol Phys (2010) 1.44
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer (2014) 1.41
Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci (2003) 1.41
2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA (2012) 1.41
Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol (2010) 1.39
Testosterone replacement therapy in men with prostate cancer: a time-varying analysis. J Sex Med (2014) 1.39
Randomized controlled trial of barbed polyglyconate versus polyglactin suture for robot-assisted laparoscopic prostatectomy anastomosis: technique and outcomes. Eur Urol (2010) 1.38
Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. J Urol (2010) 1.29
Overuse of imaging for staging low risk prostate cancer. J Urol (2011) 1.14
Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl Med (2012) 1.11
Mechanosensory and thermosensory changes across the border of impaired sensitivity to pinprick after mandibular nerve injury. J Oral Maxillofac Surg (2002) 1.11
Resting cerebral blood flow alterations in chronic traumatic brain injury: an arterial spin labeling perfusion FMRI study. J Neurotrauma (2010) 1.08
Anatomic bladder neck preservation during robotic-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2009) 1.03
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int (2011) 1.03
Overcoming the learning curve for robotic-assisted laparoscopic radical prostatectomy. Urol Clin North Am (2010) 1.03
Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer. J Sex Med (2010) 1.02
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction. Int J Radiat Oncol Biol Phys (2011) 1.00
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol (2012) 0.98
Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States. Cancer (2011) 0.97
Surgical apgar outcome score: perioperative risk assessment for radical cystectomy. J Urol (2009) 0.93
Population-based determinants of radical prostatectomy surgical margin positivity. BJU Int (2010) 0.91
Dural MALT lymphoma with disseminated disease. Hematol Rep (2010) 0.91
Stemming vision loss with stem cells. J Clin Invest (2010) 0.91
Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample. BJU Int (2009) 0.91
Stepwise description and outcomes of bladder neck sparing during robot-assisted laparoscopic radical prostatectomy. J Urol (2012) 0.90
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas. J Neurooncol (2009) 0.89
Molecular characterisation of the SAND protein family: a study based on comparative genomics, structural bioinformatics and phylogeny. Cell Mol Biol Lett (2004) 0.89
Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination. J Neurooncol (2010) 0.88
In-hospital mortality and failure-to-rescue rates after radical cystectomy. BJU Int (2013) 0.87
National trends in hospital-acquired preventable adverse events after major cancer surgery in the USA. BMJ Open (2013) 0.87
Nerve-sparing technique and urinary control after robot-assisted laparoscopic prostatectomy. World J Urol (2010) 0.87
The impact of prostate size, median lobe, and prior benign prostatic hyperplasia intervention on robot-assisted laparoscopic prostatectomy: technique and outcomes. Eur Urol (2011) 0.86
Individual physician experience with laparoscopic supracervical hysterectomy in a single outpatient setting. Surg Innov (2007) 0.86
Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy. Urology (2008) 0.86
A perfusion fMRI study of the neural correlates of sustained-attention and working-memory deficits in chronic traumatic brain injury. Neurorehabil Neural Repair (2012) 0.86
The effect of minimally invasive and open radical prostatectomy surgeon volume. Urol Oncol (2010) 0.86
Endofacial competitive inhibition of glucose transporter-4 intrinsic activity by the mitogen-activated protein kinase inhibitor SB203580. Endocrinology (2005) 0.86
Response inhibition among early adolescents prenatally exposed to tobacco: an fMRI study. Neurotoxicol Teratol (2009) 0.85
Complementary and alternative medicine use by patients chronically infected with hepatitis C virus. Can J Gastroenterol (2007) 0.85
Use of surveillance imaging following treatment of small renal masses. J Urol (2013) 0.85
Acute promyelocytic leukemia and constitutional trisomy 21. Cancer Genet Cytogenet (2006) 0.85
Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. Urol Oncol (2008) 0.85
Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study. Br J Ophthalmol (2010) 0.85
Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy. World J Urol (2011) 0.84
Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study. Psychopharmacology (Berl) (2011) 0.83
Managing cardiovascular risk in overweight children and adolescents. Paediatr Drugs (2013) 0.82
Does robotic prostatectomy meet its promise in the management of prostate cancer? Curr Urol Rep (2013) 0.82
Review of breast conservation therapy: then and now. ISRN Oncol (2011) 0.82
Tracing patients on antiretroviral treatment lost-to-follow-up in an urban slum in India. J Adv Nurs (2012) 0.82
Delayed staple erosion into the bladder after removal of a benign ovarian mass. J Minim Invasive Gynecol (2009) 0.81
Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies. World J Urol (2014) 0.81
Partial clamping of the renal artery during robot-assisted laparoscopic partial nephrectomy: technique and initial outcomes. J Endourol (2012) 0.81
Posttreatment prostate specific antigen nadir predicts prostate cancer specific and all cause mortality. J Urol (2012) 0.80
Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer. Obstet Gynecol (2016) 0.80
Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer. BJU Int (2011) 0.79
Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends. J Sex Med (2014) 0.79
Health care-associated infections after major cancer surgery: temporal trends, patterns of care, and effect on mortality. Cancer (2013) 0.79
Improved survival with single-agent paclitaxel consolidation/maintenance therapy in advanced ovarian carcinoma. Oncology (2007) 0.79
Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes. Cancer (2014) 0.79
Pericranial flap for closure of paramedian anterior skull base defects. Otolaryngol Head Neck Surg (2002) 0.79
Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy. BJU Int (2013) 0.79
Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer. Obstet Gynecol (2016) 0.78
United States comparative costs and absenteeism of diabetic ophthalmic conditions. Postgrad Med (2014) 0.78